- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05844280
The Role of Blood Flow Restriction Therapy in Postop Rehabilitation of Foot and Ankle Injuries
December 4, 2024 updated by: Michael Johnson, University of Alabama at Birmingham
The purpose of the study is to determine the role of blood flow restriction (BFR) + neuromuscular electrical stimulation (NMES) in improving post-operative physical therapy and recovery after ankle fracture surgery.
We expect to see improved muscle strength, less muscle wasting, and improved functional recovery after surgery when making these additions to routine post-operative (postop) physical therapy protocols.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Detailed Description
Few studies have examined BFR in patients sustaining operative foot and ankle injuries.
Due to the weight bearing limitations and prolonged immobilization following these injuries, patients often experience increased time away from work and delays with return to sport.
These factors are responsible for the rapid muscle atrophy that occurs in the immediate post injury period because of immobility and disuse.
Recently, blood flow restriction (BFR) therapy has been shown to be effective in improving muscle strength and preventing atrophy when combined with low load resistance training physical therapy programs.7,8
Neuromuscular electrical stimulation (NMES) is an adjunctive agent that has been show to augment the effects of BFR alone.4
The null hypothesis is that a 2 week BFR + NMES + low load resistance training program in patients age >= 18 recovering from foot and ankle surgery will have no effect on short term (2 weeks postop) lower extremity muscle hypertrophy or atrophy, patient pain and satisfaction, or functional recovery after foot and ankle surgery.
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35243
- University of Alabama at Birmingham
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- isolated, closed low-energy rotational ankle fracture without prior surgery or implants to injured area
Exclusion Criteria:
- history of Deep Vein Thrombosis in affected extremity
- history of significant cardiac disease defined as a recent stent placement in past
- history of peripheral arterial disease
- history of sickle cell disease
- history of coagulopathy
- presenting to surgery >14 days after injury
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control Group
receiving physical therapy with BFR+NMES devices used at sub-therapeutic levels
|
This means that the BFR tourniquet and the NMES device will be at such low settings as to not create the treatment effect but subject will have the equipments on their thigh during exercise
|
|
Experimental: Treatment Group
receiving physical therapy with BFR+NMES devices used at settings that are deemed by prior studies to be therapeutic
|
This group will receive therapy with BFR+NMES devices used at settings that are deemed by prior studies to be therapeutic.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assess for calf muscle atrophy as measured by calf circumference
Time Frame: 2 weeks postop
|
Calf circumference will be measured using a measuring tape
|
2 weeks postop
|
|
Assess for calf muscle atrophy as measured by hand held dynamometry
Time Frame: 2 weeks postop
|
Hand held Dynamometry will be used to measure the length-tension relationship of the muscle in pounds
|
2 weeks postop
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient tolerance of the BFR treatment using the Visual Analogue Pain Scale.
Time Frame: 2 weeks postop
|
The Visual Analogue Pain Scale is used during the beginning, midpoint, and end of a session. This scale ranges from 0-10 which 0 being "no pain" and 10 being "worst pain" |
2 weeks postop
|
|
Patient tolerance of the BFR treatment using the the Borg Rating of Perceived Exertion f
Time Frame: 2 weeks postop
|
The Borg Rating of Perceived Exertion will be used for each session and exercise. This rating ranges from 6-20 with 6 being no exertion at all, and 20 being maximum effort |
2 weeks postop
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
August 1, 2026
Primary Completion (Estimated)
August 1, 2028
Study Completion (Estimated)
December 1, 2029
Study Registration Dates
First Submitted
March 2, 2023
First Submitted That Met QC Criteria
May 3, 2023
First Posted (Actual)
May 6, 2023
Study Record Updates
Last Update Posted (Estimated)
December 9, 2024
Last Update Submitted That Met QC Criteria
December 4, 2024
Last Verified
December 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB-300009735
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fracture of Foot
-
Inion OyRecruitingFractures, Bone | Foot Deformities | Ankle Fractures | Hallux Valgus | Hallux Rigidus | Fracture of Foot | Lisfranc Fracture | Metatarsalgia | Lisfranc Injury | Deformity, Foot | Calcaneus Fracture | Talus Fracture | Medial Malleolus Fracture | Navicular Fracture | Foot Fracture | Foot Injury | Feet Deformity Tarsus | Deformity... and other conditionsFinland
-
Ochsner Health SystemUnknownStrain of Muscle and/or Tendon of Lower Leg | Fracture of Lower Leg | Crushing Injury of Lower Leg | Fracture Malunion - Ankle and/or Foot | Disorder of Joint of Ankle and/or Foot | Complete Tear, Ankle and/or Foot Ligament | Pathological Fracture - Ankle and/or Foot | Loose Body in Joint of Ankle...United States
-
Northwestern UniversityTerminatedFracture of FootUnited States
-
Jose Soberon, MDCompletedStrain of Muscle and/or Tendon of Lower Leg | Fracture of Lower Leg | Crushing Injury of Lower Leg | Complete Tear, Ankle and/or Foot Ligament | Pathological Fracture - Ankle and/or Foot | Loose Body in Joint of Ankle and/or Foot | Fracture Malunion - Ankle and/ or FootUnited States
-
Chiang Mai UniversityCompletedOpen Fracture of FootThailand
-
Balgrist University HospitalRecruitingStress Fracture Metatarsal | Lower Limb Fracture | Stress Fracture Foot | Stress Fracture Ankle | Stress Fracture of TibiaSwitzerland
-
West Virginia UniversityWithdrawnAnkle Fractures | Ankle Sprains | Apophysitis; Juvenile | Foot Fracture | Foot Sprain | Toe-walking | Tendonitis of FootUnited States
-
RTI SurgicalTerminatedFoot Deformities, Acquired | Fracture of Foot | Disorder of Joint of Foot | Deformity of BoneUnited States
-
University of ZurichWithdrawnTumor | Open Fracture of FootSwitzerland
-
FH ORTHOCompletedCalcaneus Fracture | Calcaneus Deformity of Foot | Arthrosis; LocalizedFrance
Clinical Trials on BFR+NMES at sub therapeutic level
-
University of California, San DiegoTerminatedStroke | Obstructive Sleep ApneaUnited States
-
Southern Illinois UniversityCompletedCarcinomaUnited States
-
Fisher and Paykel HealthcareCompleted